1. Home
  2. PKOH vs RGNX Comparison

PKOH vs RGNX Comparison

Compare PKOH & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKOH
  • RGNX
  • Stock Information
  • Founded
  • PKOH 1907
  • RGNX 2008
  • Country
  • PKOH United States
  • RGNX United States
  • Employees
  • PKOH N/A
  • RGNX N/A
  • Industry
  • PKOH Industrial Specialties
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PKOH Industrials
  • RGNX Health Care
  • Exchange
  • PKOH Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • PKOH 397.8M
  • RGNX 459.1M
  • IPO Year
  • PKOH N/A
  • RGNX 2015
  • Fundamental
  • Price
  • PKOH $32.19
  • RGNX $9.63
  • Analyst Decision
  • PKOH
  • RGNX Strong Buy
  • Analyst Count
  • PKOH 0
  • RGNX 12
  • Target Price
  • PKOH N/A
  • RGNX $36.36
  • AVG Volume (30 Days)
  • PKOH 32.2K
  • RGNX 673.8K
  • Earning Date
  • PKOH 11-06-2024
  • RGNX 11-06-2024
  • Dividend Yield
  • PKOH 1.55%
  • RGNX N/A
  • EPS Growth
  • PKOH N/A
  • RGNX N/A
  • EPS
  • PKOH 1.29
  • RGNX N/A
  • Revenue
  • PKOH $1,657,100,000.00
  • RGNX $84,327,000.00
  • Revenue This Year
  • PKOH $3.93
  • RGNX $7.91
  • Revenue Next Year
  • PKOH $4.64
  • RGNX $214.75
  • P/E Ratio
  • PKOH $9.61
  • RGNX N/A
  • Revenue Growth
  • PKOH 0.31
  • RGNX N/A
  • 52 Week Low
  • PKOH $22.32
  • RGNX $8.54
  • 52 Week High
  • PKOH $34.50
  • RGNX $28.80
  • Technical
  • Relative Strength Index (RSI)
  • PKOH 57.81
  • RGNX 45.77
  • Support Level
  • PKOH $32.34
  • RGNX $10.24
  • Resistance Level
  • PKOH $33.22
  • RGNX $12.11
  • Average True Range (ATR)
  • PKOH 1.24
  • RGNX 0.81
  • MACD
  • PKOH 0.28
  • RGNX 0.15
  • Stochastic Oscillator
  • PKOH 64.68
  • RGNX 29.72

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: